Faruk Sinangil

5.3k total citations
51 papers, 1.5k citations indexed

About

Faruk Sinangil is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, Faruk Sinangil has authored 51 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Virology, 24 papers in Immunology and 21 papers in Infectious Diseases. Recurrent topics in Faruk Sinangil's work include HIV Research and Treatment (34 papers), HIV/AIDS drug development and treatment (17 papers) and Immune Cell Function and Interaction (12 papers). Faruk Sinangil is often cited by papers focused on HIV Research and Treatment (34 papers), HIV/AIDS drug development and treatment (17 papers) and Immune Cell Function and Interaction (12 papers). Faruk Sinangil collaborates with scholars based in United States, Spain and Thailand. Faruk Sinangil's co-authors include Phillip W. Berman, David J. Volsky, Marc Gurwith, Donald P. Francis, William L. Heyward, David V. Jobes, Peter B. Gilbert, Michael Peterson, Kathelyn S. Steimer and Donald S. Burke and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and PLoS ONE.

In The Last Decade

Faruk Sinangil

50 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Faruk Sinangil United States 23 1.0k 608 540 412 364 51 1.5k
Zoe Moodie United States 21 1.1k 1.0× 1.1k 1.8× 837 1.6× 746 1.8× 703 1.9× 52 2.5k
Allan C. deCamp United States 13 979 0.9× 700 1.2× 511 0.9× 376 0.9× 268 0.7× 20 1.4k
David Li United States 5 721 0.7× 520 0.9× 434 0.8× 370 0.9× 350 1.0× 9 1.3k
James B. Whitney United States 21 933 0.9× 491 0.8× 734 1.4× 444 1.1× 258 0.7× 64 1.6k
Morgane Rolland United States 23 1.1k 1.1× 689 1.1× 860 1.6× 339 0.8× 602 1.7× 64 1.9k
P Thongcharoen Thailand 18 644 0.6× 371 0.6× 682 1.3× 665 1.6× 194 0.5× 77 1.5k
Colin Havenar‐Daughton United States 21 567 0.5× 1.8k 3.0× 706 1.3× 354 0.9× 484 1.3× 27 2.6k
Doreen B. Brettler United States 21 1.3k 1.3× 638 1.0× 801 1.5× 496 1.2× 276 0.8× 43 2.4k
Vladimir Novitsky United States 29 2.4k 2.3× 721 1.2× 1.9k 3.6× 685 1.7× 676 1.9× 95 3.1k
Paul T. Edlefsen United States 13 679 0.7× 306 0.5× 506 0.9× 220 0.5× 213 0.6× 31 991

Countries citing papers authored by Faruk Sinangil

Since Specialization
Citations

This map shows the geographic impact of Faruk Sinangil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Faruk Sinangil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Faruk Sinangil more than expected).

Fields of papers citing papers by Faruk Sinangil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Faruk Sinangil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Faruk Sinangil. The network helps show where Faruk Sinangil may publish in the future.

Co-authorship network of co-authors of Faruk Sinangil

This figure shows the co-authorship network connecting the top 25 collaborators of Faruk Sinangil. A scholar is included among the top collaborators of Faruk Sinangil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Faruk Sinangil. Faruk Sinangil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rallón, Norma, José M. Benito, Francisco J. Márquez, et al.. (2024). Impact of Human Leukocyte Antigen Allele–Killer Cell Immunoglobulin-like Receptor Partners on Sexually Transmitted Human Immunodeficiency Virus Type 1 Infection. The Journal of Infectious Diseases. 230(5). e1077–e1081.
2.
Machmach, Kawthar, Isabella Swafford, Margaret C. Costanzo, et al.. (2024). Innate immune cell activation after HIV-1 vaccine administration is associated with increased antibody production. Frontiers in Immunology. 15. 1339727–1339727. 2 indexed citations
3.
Mesa, Kathryn A., Bin Yu, Terri Wrin, et al.. (2019). Ancestral sequences from an elite neutralizer proximal to the development of neutralization resistance as a potential source of HIV vaccine immunogens. PLoS ONE. 14(4). e0213409–e0213409. 3 indexed citations
4.
Balasubramanian, Preetha, Constance Williams, Faruk Sinangil, et al.. (2018). Functional Antibody Response Against V1V2 and V3 of HIV gp120 in the VAX003 and VAX004 Vaccine Trials. Scientific Reports. 8(1). 542–542. 19 indexed citations
5.
Akapirat, Siriwat, Chitraporn Karnasuta, Sandhya Vasan, et al.. (2018). Characterization of HIV-1 gp120 antibody specificities induced in anogenital secretions of RV144 vaccine recipients after late boost immunizations. PLoS ONE. 13(4). e0196397–e0196397. 11 indexed citations
6.
Balasubramanian, Preetha, Rajnish Kumar, Constance Williams, et al.. (2017). Differential induction of anti-V3 crown antibodies with cradle- and ladle-binding modes in response to HIV-1 envelope vaccination. Vaccine. 35(10). 1464–1473. 10 indexed citations
7.
Karnasuta, Chitraporn, Siriwat Akapirat, Supachai Rerks‐Ngarm, et al.. (2016). Comparison of Antibody Responses Induced by RV144, VAX003, and VAX004 Vaccination Regimens. AIDS Research and Human Retroviruses. 33(5). 410–423. 27 indexed citations
8.
Pérez‐Losada, Marcos, David V. Jobes, Faruk Sinangil, et al.. (2011). Phylodynamics of HIV-1 from a Phase III AIDS Vaccine Trial in Bangkok, Thailand. PLoS ONE. 6(3). e16902–e16902. 27 indexed citations
9.
Smith, Douglas H., Sara M. O’Rourke, Faruk Sinangil, et al.. (2010). Comparative Immunogenicity of HIV-1 Clade C Envelope Proteins for Prime/Boost Studies. PLoS ONE. 5(8). e12076–e12076. 15 indexed citations
10.
Pérez‐Losada, Marcos, David Posada, Miguel Arenas, et al.. (2009). Ethnic differences in the adaptation rate of HIV gp120 from a vaccine trial. Retrovirology. 6(1). 67–67. 19 indexed citations
11.
Pérez‐Losada, Marcos, David V. Jobes, Faruk Sinangil, et al.. (2009). Phylodynamics of HIV-1 from a Phase-III AIDS Vaccine Trial in North America. Molecular Biology and Evolution. 27(2). 417–425. 16 indexed citations
12.
Jobes, David V., Faruk Sinangil, Marcos Pérez‐Losada, et al.. (2006). Longitudinal Population Analysis of Dual Infection with Recombination in Two Strains of HIV Type 1 Subtype B in an Individual from a Phase 3 HIV Vaccine Efficacy Trial. AIDS Research and Human Retroviruses. 22(10). 968–978. 8 indexed citations
13.
Jobes, David V., et al.. (2006). High Incidence of Unusual Cysteine Variants in gp120 Envelope Proteins from Early HIV Type 1 Infections from a Phase 3 Vaccine Efficacy Trial. AIDS Research and Human Retroviruses. 22(10). 1014–1021. 13 indexed citations
14.
Rothstein, Edward, Edwin L. Anderson, Michael D. Decker, et al.. (1999). An acellular pertussis vaccine in healthy adults: safety and immunogenicity. Vaccine. 17(23-24). 2999–3006. 22 indexed citations
15.
Zolla‐Pazner, Susan, Carl R. Alving, Robert B. Belshe, et al.. (1997). Neutralization of a Clade B Primary Isolate by Sera from Human Immunodeficiency Virus—Uninfected Recipients of Candidate AIDS Vaccines. The Journal of Infectious Diseases. 175(4). 764–774. 39 indexed citations
16.
Volsky, David J., et al.. (1986). HTLV-III/LAV ANTIBODIES AND VIRUS IN HEMOPHILIA PATIENTS IN NEBRASKA: SURVEY AND INITIATION OF A PROSPECTIVE STUDY. PubMed. 2(1). 51–61. 2 indexed citations
17.
Dewhurst, Stephen, et al.. (1986). ANTIBODIES TO ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)-ASSOCIATED VIRUS (HTLV-III/LAV) IN VENEZUELAN POPULATIONS. PubMed. 2(2). 79–92. 6 indexed citations
18.
Dewhurst, Stephen, et al.. (1986). Testing for antibodies to AIDS‐associated retrovirus (HTLV‐III/LAV) by indirect fixed cell immunofluorescence: Specificity, sensitivity, and applications. Journal of Medical Virology. 19(4). 325–334. 19 indexed citations
19.
20.
Casareale, D, Stephen Dewhurst, Joseph Sonnabend, et al.. (1983). PREVALENCE OF AIDS-ASSOCIATED RETROVIRUS AND ANTIBODIES AMONG MALE HOMOSEXUALS AT RISK FOR AIDS IN GREENWICH VILLAGE. PubMed. 1(6). 407–421. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zoe Moodie Breakdown of academic impact, for papers by Allan C. deCamp Breakdown of academic impact, for papers by David Li Breakdown of academic impact, for papers by James B. Whitney Breakdown of academic impact, for papers by Morgane Rolland Breakdown of academic impact, for papers by P Thongcharoen Breakdown of academic impact, for papers by Colin Havenar‐Daughton Breakdown of academic impact, for papers by Doreen B. Brettler Breakdown of academic impact, for papers by Vladimir Novitsky Breakdown of academic impact, for papers by Paul T. Edlefsen
Rankless by CCL
2026